Factors regulating the transcriptional elongation activity of RNA polymerase II

The synthesis of mature and functional messenger RNA by eukaryotic RNA polymerase II (Pol II) is a complex, multistage process requiring the cooperative action of many cellular proteins. This process, referred to collectively as the transcription cycle, proceeds via five stages: preinitiation, initiation, promoter clearance, elongation, and termination. During the past few years, fundamental studies of the elongation stage of transcription have demonstrated the existence of several families of Pol II elongation factors governing the activity of Pol II. It is now clear that the elongation stage of transcription is a critical stage for the regulation of gene expression. In fact, two of these elongation factors, ELL and elongin, have been implicated in human cancer. This article will review the proteins involved in the regulation of the elongation stage of transcription by Pol II, describing the recent experimental findings that have propelled vigorous research on the properties and function of the elongating RNA polymerase II.—Shilatifard, A. Factors regulating the transcriptional elongation activity of RNA polymerase II. FASEB J. 12, 1437–1446 (1998)

[1]  D. K. Hawley,et al.  Transcriptional Fidelity and Proofreading by RNA Polymerase II , 1998, Cell.

[2]  A. Shilatifard.  Identification and Purification of the Holo-ELL Complex , 1998, The Journal of Biological Chemistry.

[3]  R. Conaway,et al.  The Elongin BC complex and the von Hippel-Lindau tumor suppressor protein. , 1998, Biochimica et biophysica acta.

[4]  J. Milton,et al.  Identification of multiple cyclin subunits of human P-TEFb. , 1998, Genes & development.

[5]  Ping Wei,et al.  A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.

[6]  D. Price,et al.  Unusual Nucleic Acid Binding Properties of Factor 2, an RNA Polymerase II Transcript Release Factor* , 1998, The Journal of Biological Chemistry.

[7]  F. Winston,et al.  Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae. , 1998, Genes & development.

[8]  K. Yano,et al.  DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. , 1998, Genes & development.

[9]  W. Kaelin,et al.  Regulation of Hypoxia-Inducible mRNAs by the von Hippel-Lindau Tumor Suppressor Protein Requires Binding to Complexes Containing Elongins B/C and Cul2 , 1998, Molecular and Cellular Biology.

[10]  G. Orphanides,et al.  FACT, a Factor that Facilitates Transcript Elongation through Nucleosomes , 1998, Cell.

[11]  D. Price,et al.  Zhi Xie and David H . Price Transcript Release Factor Unusual Nucleic Acid Binding Properties of Factor 2 , an RNA Polymerase II , 1998 .

[12]  J. T. Kadonaga.  Eukaryotic Transcription : An Interlaced Review Network of Transcription Factors and Chromatin-Modifying Machines , 1998 .

[13]  E. Geiduschek,et al.  Mechanism of transcription through the nucleosome by eukaryotic RNA polymerase. , 1997, Science.

[14]  G. Crabtree,et al.  Protein acetylation: more than chromatin modification to regulate transcription. , 1997, Chemistry & biology.

[15]  A. Wolffe.  Transcription control: Repressed repeats express themselves , 1997, Current Biology.

[16]  M. Mathews,et al.  Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. , 1997, Genes & development.

[17]  D. Hazuda,et al.  P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. , 1997, Genes & development.

[18]  M. Seto,et al.  Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleus , 1997, Oncogene.

[19]  M. Grunstein.  Histone acetylation in chromatin structure and transcription , 1997, Nature.

[20]  D. Luse,et al.  The H3/H4 Tetramer Blocks Transcript Elongation by RNA Polymerase II in Vitro * , 1997, The Journal of Biological Chemistry.

[21]  P. Hokland,et al.  A novel MLL-AF10 fusion mRNA variant in a patient with acute myeloid leukemia detected by a new asymmetric reverse transcription PCR method , 1997, Leukemia.

[22]  A. Shilatifard,et al.  Structure and Function of RNA Polymerase II Elongation Factor ELL , 1997, The Journal of Biological Chemistry.

[23]  M. Chamberlin,et al.  Basic mechanisms of transcript elongation and its regulation. , 1997, Annual review of biochemistry.

[24]  T. Tsukiyama,et al.  Chromatin remodeling and transcription. , 1997, Current opinion in genetics & development.

[25]  R. Klausner,et al.  The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. Caldas,et al.  EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Wickens,et al.  The C-terminal domain of RNA polymerase II couples mRNA processing to transcription , 1997, Nature.

[28]  Arndt Borkhardt,et al.  Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23) , 1997, Oncogene.

[29]  A. Shilatifard,et al.  ELL2, a new member of an ELL family of RNA polymerase II elongation factors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  B. Roe,et al.  Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia. , 1997, Genes, chromosomes & cancer.

[31]  D. K. Hawley,et al.  Promoter Proximal Sequences Modulate RNA Polymerase II Elongation by a Novel Mechanism , 1996, Cell.

[32]  D. Price,et al.  Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase* , 1996, The Journal of Biological Chemistry.

[33]  P. Sharp,et al.  Tat-SF1: Cofactor for Stimulation of Transcriptional Elongation by HIV-1 Tat , 1996, Science.

[34]  M. Arpin,et al.  The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Conaway,et al.  The RNA polymerase II general elongation factors. , 1996, Trends in biochemical sciences.

[36]  D. Edmondson,et al.  Chromatin and transcription , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  A. Aguilera,et al.  Differential intrachromosomal hyper-recombination phenotype of spt4 and spt6 mutants of S. cerevisiae , 1996, Current Genetics.

[38]  D. Bentley,et al.  TFIIH functions in regulating transcriptional elongation by RNA polymerase II in Xenopus oocytes , 1996, Molecular and cellular biology.

[39]  Steven A. Brown,et al.  Activator-dependent regulation of transcriptional pausing on nucleosomal templates. , 1996, Genes & development.

[40]  T. Rabbitts,et al.  An Mll–AF9 Fusion Gene Made by Homologous Recombination Causes Acute Leukemia in Chimeric Mice: A Method to Create Fusion Oncogenes , 1996, Cell.

[41]  F. Spencer,et al.  Faithful chromosome transmission requires Spt4p, a putative regulator of chromatin structure in Saccharomyces cerevisiae , 1996, Molecular and cellular biology.

[42]  D. Price,et al.  Purification of an RNA Polymerase II Transcript Release Factor from Drosophila(*) , 1996, The Journal of Biological Chemistry.

[43]  C. Peterson.  Multiple SWItches to turn on chromatin? , 1996, Current opinion in genetics & development.

[44]  A. Shilatifard,et al.  An RNA Polymerase II Elongation Factor Encoded by the Human ELL Gene , 1996, Science.

[45]  R. Klausner,et al.  Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. , 1996, Biochimica et biophysica acta.

[46]  C. Croce,et al.  Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[47]  S. Korsmeyer,et al.  Altered Hox expression and segmental identity in Mll-mutant mice , 1995, Nature.

[48]  D. Duan,et al.  Inhibition of transcription elongation by the VHL tumor suppressor protein , 1995, Science.

[49]  William Arbuthnot Sir Lane,et al.  Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[50]  D. Price,et al.  Purification of P-TEFb, a Transcription Factor Required for the Transition into Productive Elongation (*) , 1995, The Journal of Biological Chemistry.

[51]  W. Gu,et al.  Identification of a decay in transcription potential that results in elongation factor dependence of RNA polymerase II , 1995, The Journal of Biological Chemistry.

[52]  Y. Yazaki,et al.  Cloning of several species of MLL/MEN chimeric cDNAs in myeloid leukemia with t(11;19)(q23;p13.1) translocation. , 1995, Blood.

[53]  H. Klamut,et al.  The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced , 1995, Nature Genetics.

[54]  R. Kornberg,et al.  Interplay between chromatin structure and transcription. , 1995, Current opinion in cell biology.

[55]  J. Rowley,et al.  Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Itoh,et al.  Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions , 1994, The Journal of cell biology.

[57]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[58]  M. Cleary,et al.  ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. , 1994, Blood.

[59]  P. Hanawalt,et al.  Transcript cleavage by RNA polymerase II arrested by a cyclobutane pyrimidine dimer in the DNA template. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[60]  M. Rudd,et al.  The active site of RNA polymerase II participates in transcript cleavage within arrested ternary complexes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[61]  William Arbuthnot Sir Lane,et al.  Molecular cloning of an essential subunit of RNA polymerase II elongation factor SIII. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[62]  J. Minna,et al.  Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. , 1994, Oncogene.

[63]  G. Felsenfeld,et al.  A histone octamer can step around a transcribing polymerase without leaving the template , 1994, Cell.

[64]  R. Conaway,et al.  RNA polymerase II transcription factor SIII. I. Identification, purification, and properties. , 1993, The Journal of biological chemistry.

[65]  M. Itoh,et al.  Occludin: a novel integral membrane protein localizing at tight junctions , 1993, The Journal of cell biology.

[66]  C. V. Van Itallie,et al.  The tight junction protein ZO-1 is homologous to the Drosophila discs-large tumor suppressor protein of septate junctions. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[67]  S Wright,et al.  Regulation of eukaryotic gene expression by transcriptional attenuation. , 1993, Molecular biology of the cell.

[68]  D. Reines,et al.  Elongation factor SII-dependent transcription by RNA polymerase II through a sequence-specific DNA-binding protein. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[69]  H. Alder,et al.  The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene , 1992, Cell.

[70]  Michael L. Cleary,et al.  Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias , 1992, Cell.

[71]  F. Winston,et al.  Yeast SNF/SWI transcriptional activators and the SPT/SIN chromatin connection. , 1992, Trends in genetics : TIG.

[72]  G. Felsenfeld,et al.  A nucleosome core is transferred out of the path of a transcribing polymerase , 1992, Cell.

[73]  D. Luse,et al.  Factor-stimulated RNA polymerase II transcribes at physiological elongation rates on naked DNA but very poorly on chromatin templates. , 1992, The Journal of biological chemistry.

[74]  G. Felsenfeld,et al.  Chromatin as an essential part of the transcriptional mechanim , 1992, Nature.

[75]  R. Kornberg,et al.  Irresistible force meets immovable object: Transcription and the nucleosome , 1991, Cell.

[76]  F. Winston,et al.  SPT5, an essential gene important for normal transcription in Saccharomyces cerevisiae, encodes an acidic nuclear protein with a carboxy-terminal repeat , 1991, Molecular and cellular biology.

[77]  M. Groudine,et al.  Transcription elongation and eukaryotic gene regulation. , 1990, Oncogene.

[78]  D. Hogness,et al.  Spatial and temporal patterns of E74 transcription during Drosophila development , 1990, Cell.

[79]  A. Sluder,et al.  Dynamic interaction between a Drosophila transcription factor and RNA polymerase II , 1989, Molecular and cellular biology.

[80]  P. Sharp,et al.  5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. , 1989, The Journal of biological chemistry.

[81]  K. Yamamoto,et al.  Early events in the stimulation of mammary tumor virus RNA synthesis by glucocorticoids. Novel assays of transcription rates. , 1984, The Journal of biological chemistry.

[82]  David S. UckerS,et al.  Early Events in the Stimulation of Mammary Tumor Virus RNA Synthesis by Glucocorticoids , 1984 .

[83]  M. Chamberlin,et al.  Pausing and termination of transcription within the early region of bacteriophage T7 DNA in vitro. , 1981, The Journal of biological chemistry.

[84]  I. Tamm,et al.  Early termination of heterogeneous nuclear RNA transcripts in mammalian cells: accentuation by 5,6-dichloro 1-beta-D-ribofuranosylbenzimidazole. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[85]  N. Kobayashi,et al.  Purification of a factor from Ehrlich ascites tumor cells specifically stimulating RNA polymerase II. , 1976, Biochemistry.

[86]  J. Darnell,et al.  5,6-Dichloro-1-Beta-D-ribofuranosylbenzimidazole inhibits initiation of nuclear heterogeneous RNA chains in HeLa cells. , 1976, Science.

[87]  J. A. Allen.  THE PROBABLE ORIGIN OF CERTAIN BIRDS. , 1905, Science.